How should I manage a patient with an ammonia level of 234 µmol/L?

Management of Ammonia Level 234 µmol/L

An ammonia level of 234 µmol/L represents severe hyperammonemia requiring urgent intervention, as levels ≥200 µmol/L are independently associated with significantly increased mortality risk and warrant immediate ammonia-lowering therapy along with neuroprotective measures.

Immediate Risk Assessment

This ammonia level crosses the critical threshold of 200 µmol/L, which carries an odds ratio of 3.3 for mortality within 48 hours 1. The urgency of your response depends on:

• Mental status: Any altered consciousness, confusion, or encephalopathy indicates acute neurotoxicity requiring ICU-level care
• Underlying cause: Liver failure patients tolerate hyperammonemia less well than urea cycle defects at equivalent levels 1
• Rapidity of onset: Acute elevations pose higher risk of fatal cerebral edema than chronic hyperammonemia 2

Diagnostic Confirmation and Differential

Before proceeding with aggressive treatment, verify the ammonia measurement was obtained correctly 3:

• Fasting venous sample without tourniquet or fist clenching
• EDTA tube immediately placed on ice
• Transported to lab within 60-90 minutes at +4°C
• No hemolysis or lipemia

If the patient has altered consciousness, this ammonia level confirms hepatic encephalopathy (HE) as the working diagnosis 4. However, you must also consider:

• Non-hepatic causes if liver function is relatively preserved: urea cycle disorders, drugs (valproate, chemotherapy), infections, or post-transplant complications 2, 5
• Brain imaging (CT/MRI) is indicated during first HE episode or if diagnostic doubt exists, particularly to exclude intracranial hemorrhage in cirrhotic/alcohol-using patients 4, 3

Immediate Management Algorithm

1. Neuroprotective Measures (if altered consciousness present)

• ICU admission for close neurological monitoring
• Avoid sedatives that worsen encephalopathy
• Monitor for cerebral edema clinically; consider transcranial Doppler if available 6
• Intubation if Glasgow Coma Scale deteriorating

2. Reduce Ammonia Production

• Protein restriction: Temporarily reduce to 0-0.5 g/kg/day, then advance as tolerated 6, 7
• Reverse catabolism: Provide adequate calories (glucose) to prevent muscle breakdown
• Lactulose: 20-30g orally 2-4 times daily, titrate to 2-3 soft stools per day 7
• Rifaximin: 550mg twice daily (synergistic with lactulose) 7

3. Enhance Ammonia Removal

For levels ≥200 µmol/L with altered consciousness, strongly consider renal replacement therapy 2, 5:

• Continuous renal replacement therapy (CRRT) is most effective for rapid ammonia clearance
• Particularly critical in non-hepatic causes where cerebral edema risk is highest
• Should be initiated urgently, not delayed for "medical management failure"

Ammonia scavengers (though underutilized in liver failure compared to urea cycle defects 1):

• Consider in severe cases, especially if non-hepatic etiology suspected
• Examples: sodium benzoate, sodium phenylacetate, or L-ornithine L-aspartate

4. Identify and Treat Precipitants

• Gastrointestinal bleeding
• Infection (spontaneous bacterial peritonitis, pneumonia, UTI)
• Constipation
• Medications (benzodiazepines, opioids)
• Dehydration/electrolyte disturbances
• Large portosystemic shunts (may require closure) 7

Prognostic Implications

This ammonia level predicts poor outcomes 1:

• 28-day mortality risk increases significantly above 200 µmol/L
• Even after clinical recovery, persistent mild hyperammonemia predicts future HE episodes and hospitalizations 4
• In acute-on-chronic liver failure with overt HE, ammonia has prognostic value for transplant-free survival 4

Common Pitfalls to Avoid

1. Delaying aggressive treatment: At 234 µmol/L, this is not a "watch and wait" situation—cerebral edema can develop rapidly
2. Assuming liver disease is the cause: If liver function tests are only mildly abnormal with severe neurological impairment, suspect inherited metabolic disorders 3
3. Using ammonia to monitor treatment response: While ammonia-lowering is the goal, clinical improvement (mental status) is the primary endpoint; ammonia may remain elevated after clinical resolution 4
4. Overlooking non-hepatic causes: Increasingly recognized in ICU settings and may require different management approaches 2, 5

Follow-up Monitoring

• Serial ammonia measurements are not routinely needed once treatment initiated and patient improving clinically 4
• However, post-recovery ammonia levels do predict future decompensation risk 3
• Focus monitoring on clinical response: mental status, asterixis resolution, ability to perform cognitive tasks

The key message: 234 µmol/L is above the mortality threshold and demands urgent, aggressive ammonia-lowering therapy with strong consideration for renal replacement therapy if consciousness is impaired 1, 5.